Northwest Biotherapeutics (NWBO) Enterprise Value (QoQ) (2010 - 2026)
Northwest Biotherapeutics (NWBO) Enterprise Value (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,946.26 Bn | 1,946.20 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.25 Bn | 468.46 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.17 Bn | 115.92 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.54 Bn | 60.79 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - |
| 8 | Argenx Se | 56.91 Bn | 51.72 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.23 Bn | 38.23 Bn | - |
| 10 | Northwest Biotherapeutics | 277.35 Mn | 275.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.25% |
| Dec 31, 2025 | 33.33% |
| Sep 30, 2025 | -5.65% |
| Jun 30, 2025 | -55.31% |
| Mar 31, 2025 | -27.77% |
| Dec 31, 2024 | 26.00% |
| Sep 30, 2024 | -2.01% |
| Jun 30, 2024 | -16.26% |
| Mar 31, 2024 | -16.56% |
| Dec 31, 2023 | 65.13% |
| Sep 30, 2023 | -328.16% |
| Jun 30, 2023 | 77.00% |
| Mar 31, 2023 | 11.11% |
| Dec 31, 2022 | 26.10% |
| Sep 30, 2022 | -95.09% |
| Jun 30, 2022 | 30.62% |
| Mar 31, 2022 | 54.10% |
| Dec 31, 2021 | -295.44% |
| Sep 30, 2021 | -2.08% |
| Jun 30, 2021 | 49.68% |